George Daneker
Myriad Genetics Inc., a Salt Lake City-based company focused on genetic testing and precision medicine, has appointed Dr. George Daneker Jr. as president and chief clinical officer of oncology, effective March 18. Daneker will be responsible for leading the commercial and clinical strategy to advance Myriad’s oncology portfolio. Daneker has more than 30 years of oncology and precision medicine experience, most recently serving as the system vice president for oncology and medical director of the Oncology Clinical Program at SSM Health. Prior to that, he was the system corporate chief medical officer at City of Hope (Formerly Cancer Treatment Centers of America).
